Pablo Martín-Gago

Hit Discovery

Pablo is currently a Principal Scientist and the head of the Hit Discovery team at LEO Pharma, where he leads chemical biology and medicinal chemistry efforts to identify, validate and develop novel molecules for treating skin diseases. Pablo Martín-Gago completed his Ph.D. at the IRB Barcelona with Prof. A. Riera. After a research stay in the Fu Lab at Caltech, he joined the Max Planck Institute as a postdoc with Prof. H. Waldmann to develop inhibitors of the KRas-PDEδ interaction. After joining Copenhagen University as an assistant professor designing covalent probes for epigenetic targets, he moved to Lundbeck, where he worked on multiple hit-finding campaigns and early-stage drug discovery projects targeting CNS disorders. 

More from Pablo

Join the Drug Hunter Mailing List

to get free content and resources weekly. Trusted by >15,000 drug hunters worldwide. Unsubscribe anytime.